OpenEvidence, an AI search engine for doctors, has raised $250 million in Series D funding, doubling its valuation to $12 billion in three months, reflecting the increasing investor interest and premium valuations in AI-driven healthcare solutions.
The key insight for someone interested in startup funding and venture capital is the significant valuation growth in AI startups, as exemplified by OpenEvidence's $12 billion valuation following a $250 million Series D round. This reflects a broader trend where premiums for AI companies are increasing due to intensified competition and perceived investment upside, particularly in sectors like healthcare where AI applications are rapidly advancing.